Please use this identifier to cite or link to this item:
|Title:||Analogues designing for dephosphorylation of acetylcholinesterase enzyme|
Singh, B K
Choudhary, Bhanwar S
|Keywords:||Ligand based drug design;structure based drug design;LOPAC database;virtual screening;docking;analogue designing;pharmacokinetic parameters|
|Abstract:||Organophosphate (OP) causes phosphorylation of acetylcholinesterase enzyme which leads to accumulation of acetylcholine. This phosphorylation generally occurs due to exposure of nerve agents and intake of pesticides, etc. Various standard drugs specifically oxime derivatives (HI-6, Obidoxime, 2-PAM, etc.) are used as AChE enzyme reactivation agents. These standard drugs show least penetration to CNS. Taking them into consideration with the help of structure and ligand based screened compounds, various small molecules analogues targeting CNS have been designed. These analogues pass all the pharmacokinetic parameters structurally and have also shown better results than that of standards. Among various charged and uncharged analogues, 4g, 4h and 4j have attained docking scores –13.11, –12.84 and –12.75Kcal/mol respectively which is better than that of the standard (HI-6) –12.13kcal/mol.|
|Appears in Collections:||IJC-B Vol.60B(06) [June 2021]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.